Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Filament Health Corp (OP:FLHLF)

0.0001 UNCHANGED
Last Price Updated: 11:58 AM EST, Dec 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Filament Health Corp

< Previous 1 2 3 Next >
News headline image
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill ↗
Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider. 
Via Benzinga
News headline image
Two Psychedelics Drug Development Companies Work To Produce Novel Plant-Based Compounds For Mental Health Disorders ↗
Filament Health Corp. (OTCQB: FLHLF) and Jaguar Health, Inc. (NASDAQ: JAGX) have signed a letter of intent for a collaboration agreement. 
Via Benzinga
News headline image
Optimi Health Signs Two New Supply Agreements In Less Than a Week ↗
Optimi (OPTHF), the Canadian, home-grown mushroom formulations producer has signed not one but two supply deals with different research companies. 
Via Benzinga
News headline image
Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say ↗
Patents are the golden eggs of the booming psychedelic space. 
Via Benzinga
News headline image
Filament Health Keeps Adding Patents To Its Portfolio, Just Received Its Fourth ↗
Just two weeks ago, Filament Health (OTCQB: FLHLF) was issued a patent by the U. S. Patent and Trademark Office to extract and standardize natural psilocybin. 
Via Benzinga
News headline image
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... 
Via Benzinga
News headline image
Filament Health Talks Psilocybins, Psilocins And How Natural Psychedelics Could Conquer The Market ↗
Filament Health (OTCQB: FLHLF) (NEO:FH) is a clinical-stage psychedelic drug development company creating safe, standardized, naturally-derived psychedelic medicines. 
Via Benzinga
News headline image
Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know ↗
Psyence Group (OTCQB: PSYGF) and Filament Health Corp. (OTCQB: FLHLF) announced the signing of a licensing agreement: Filament is to license its proprietary psilocybin derived drug, PEX010, and the... 
Via Benzinga
News headline image
Filament Health Acquires Patent For Extracting And Standardizing Natural Psilocybin ↗
Filament Health Corp. (OTCQB: FLHLF) announced that the U. S. Patent and Trademark Office (USPTO) issued a patent that will allow the company to extract and standardize natural psilocybin and... 
Via Benzinga
Filament Health Corp. (FLHLF) Featured in Virtual Coverage of the 34th Annual Roth Conference
Via Investor Brand Network
Topics Intellectual Property
News headline image
Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins ↗
This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE. 
Via Benzinga
News headline image
Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants ↗
Health Canada has allowed a phase 2 clinical trial of psilocybin in patients currently undergoing treatment with traditional antidepressants. 
Via Benzinga
News headline image
Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington ↗
Canada Opens New Legal Pathways For Access To Treatment With Psilocybin And MDMA In a groundbreaking decision, the Canadian gov... 
Via Benzinga
News headline image
How One Company Says It Aims To Demonstrate the Superiority of Psilocin Over Psilocybin in Treating Mental Health Conditions ↗
Image by Mathew Schwartz from Unsplash The following post was written and/or pu... 
Via Benzinga
News headline image
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval ↗
Detroit Decriminalizes Psychedelics 
Via Benzinga
News headline image
The Power Play by The Market Herald Releases New Interviews with Filament Health, Kidoz Inc., Falcon Gold, Psyched Wellness, Maven Brands Inc., and Xali Gold Corp.
VANCOUVER, BC / ACCESSWIRE / November 3, 2021 / The Power Play by The Market Herald has announced the release of new interviews with Filament Health, Kidoz Inc., Falcon Gold, Psyched Wellness, Maven... 
From The Market Herald
Via AccessWire
Topics Cannabis
News headline image
Psychedelic Stock Filament Health Jumps On Announcing First Psilocin Clinical Trial ↗
Psychedelic drug discovery company Filament Health Corp. (OTCQB: 
Via Benzinga
News headline image
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗
The Week In Psychedelics 
Via Benzinga
News headline image
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.